Mitochondria in Multiple Sclerosis: Molecular Mechanisms of Pathogenesis

International Review of Cell and Molecular Biology

Volumn 328, Issue , 2017, Pages 49-103

  Patergnani, S ^a   Fossati, V ^b   Bonora, M ^a   Giorgi, C ^a   Marchi, S ^a   Missiroli, S ^a   Rusielewicz, T ^b   Wieckowski, M R ^c   Pinton, P ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b New York Stem Cell Foundation   (United States)

^c NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

mitochondria; multiple sclerosis; oligodendrocytes; therapy

Indexed keywords

CUPRIZONE; ION; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN;

APOPTOSIS; ASTROCYTE; AUTOPHAGY; BRAIN SLICE; CELL DEATH; CELL METABOLISM; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; COCULTURE; CUPRIZONE-INDUCED DEMYELINATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; HUMAN; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOGENESIS; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; MULTIPLE SCLEROSIS; NERVE DEGENERATION;

EID: 85008626235     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2016.08.003     Document Type: Chapter

References (280)

1. Adams, J.M., Cory, S., Apoptosomes: engines for caspase activation. Curr. Opin. Cell Biol. 14 (2002), 715–720.
2. Agholme, L., Lindstrom, T., Kagedal, K., Marcusson, J., Hallbeck, M., An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J. Alzheimers Dis. 20 (2010), 1069–1082.
3. Aktas, O., Prozorovski, T., Zipp, F., Death ligands and autoimmune demyelination. Neuroscientist 12 (2006), 305–316.
4. Alirezaei, M., Fox, H.S., Flynn, C.T., Moore, C.S., Hebb, A.L., Frausto, R.F., Bhan, V., Kiosses, W.B., Whitton, J.L., Robertson, G.S., Crocker, S.J., Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis. Autophagy 5 (2009), 152–158.
5. Amaral, A.I., Hadera, M.G., Tavares, J.M., Kotter, M.R., Sonnewald, U., Characterization of glucose-related metabolic pathways in differentiated rat oligodendrocyte lineage cells. Glia 64 (2016), 21–34.
6. Andalib, S., Talebi, M., Sakhinia, E., Farhoudi, M., Sadeghi-Bazargani, H., Gjedde, A., Mitochondrial DNA T4216C and A4917G variations in multiple sclerosis. J. Neurol. Sci. 356 (2015), 55–60.
7. Andalib, S., Talebi, M., Sakhinia, E., Farhoudi, M., Sadeghi-Bazargani, H., Motavallian, A., Pilehvar-Soltanahmadi, Y., Multiple sclerosis and mitochondrial gene variations: a review. J. Neurol. Sci. 330 (2013), 10–15.
8. Antel, J., Antel, S., Caramanos, Z., Arnold, D.L., Kuhlmann, T., Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?. Acta Neuropathol. 123 (2012), 627–638.
9. Anthony, D.C., Hughes, P., Perry, V.H., [The evidence for primary axonal loss in multiple sclerosis]. Rev. Neurol. 30 (2000), 1203–1208.
10. Arduino, D.M., Esteves, A.R., Swerdlow, R.H., Cardoso, S.M., A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease. Methods Mol. Biol. 1265 (2015), 415–424.
11. Ashrafi, G., Schlehe, J.S., Lavoie, M.J., Schwarz, T.L., Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J. Cell Biol. 206 (2014), 655–670.
12. Bajt, M.L., Farhood, A., Lemasters, J.J., Jaeschke, H., Mitochondrial bax translocation accelerates DNA fragmentation and cell necrosis in a murine model of acetaminophen hepatotoxicity. J. Pharmacol. Exp. Ther. 324 (2008), 8–14.
13. Barnett, M.H., Prineas, J.W., Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann. Neurol. 55 (2004), 458–468.
14. Barnett, S.C., Linington, C., Myelination: do astrocytes play a role?. Neuroscientist 19 (2013), 442–450.
15. Barnhart, B.C., Alappat, E.C., Peter, M.E., The CD95 type I/type II model. Semin. Immunol. 15 (2003), 185–193.
16. Baughman, J.M., Perocchi, F., Girgis, H.S., Plovanich, M., Belcher-Timme, C.A., Sancak, Y., Bao, X.R., Strittmatter, L., Goldberger, O., Bogorad, R.L., Koteliansky, V., Mootha, V.K., Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476 (2011), 341–345.
17. Baumann, N., Pham-Dinh, D., Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81 (2001), 871–927.
18. Belanger, M., Allaman, I., Magistretti, P.J., Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14 (2011), 724–738.
19. Bellavista, E., Santoro, A., Galimberti, D., Comi, C., Luciani, F., Mishto, M., Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis. Autoimmune Dis., 2014, 2014, 739705.
20. Ben-Ari, Z., Pappo, O., Cheporko, Y., Yasovich, N., Offen, D., Shainberg, A., Leshem, D., Sulkes, J., Vidne, B.A., Hochhauser, E., Bax ablation protects against hepatic ischemia/reperfusion injury in transgenic mice. Liver Transpl. 13 (2007), 1181–1188.
21. Block, M.L., NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci., 9(Suppl. 2), 2008, S8.
22. Blokhin, A., Vyshkina, T., Komoly, S., Kalman, B., Variations in mitochondrial DNA copy numbers in MS brains. J. Mol. Neurosci. 35 (2008), 283–287.
23. Bolanos, J.P., Almeida, A., Stewart, V., Peuchen, S., Land, J.M., Clark, J.B., Heales, S.J., Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68 (1997), 2227–2240.
24. Bonda, D.J., Wang, X., Perry, G., Smith, M.A., Zhu, X., Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies. Drugs Aging 27 (2010), 181–192.
25. Bonora, M., Bononi, A., De Marchi, E., Giorgi, C., Lebiedzinska, M., Marchi, S., Patergnani, S., Rimessi, A., Suski, J.M., Wojtala, A., Wieckowski, M.R., Kroemer, G., Galluzzi, L., Pinton, P., Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12 (2013), 674–683.
26. Bonora, M., De Marchi, E., Patergnani, S., Suski, J.M., Celsi, F., Bononi, A., Giorgi, C., Marchi, S., Rimessi, A., Duszynski, J., Pozzan, T., Wieckowski, M.R., Pinton, P., Tumor necrosis factor-alpha impairs oligodendroglial differentiation through a mitochondria-dependent process. Cell Death Differ. 21 (2014), 1198–1208.
27. Bonora, M., Morganti, C., Morciano, G., Giorgi, C., Wieckowski, M.R., Pinton, P., Comprehensive analysis of mitochondrial permeability transition pore activity in living cells using fluorescence-imaging-based techniques. Nat. Protoc. 11 (2016), 1067–1080.
28. Bonora, M., Patergnani, S., Rimessi, A., De Marchi, E., Suski, J.M., Bononi, A., Giorgi, C., Marchi, S., Missiroli, S., Poletti, F., Wieckowski, M.R., Pinton, P., ATP synthesis and storage. Purinergic Signal. 8 (2012), 343–357.
29. Bonora, M., Wieckowski, M.R., Chinopoulos, C., Kepp, O., Kroemer, G., Galluzzi, L., Pinton, P., Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition. Oncogene 34 (2015), 1475–1486.
30. Boulanger, J.J., Messier, C., From precursors to myelinating oligodendrocytes: contribution of intrinsic and extrinsic factors to white matter plasticity in the adult brain. Neuroscience 269 (2014), 343–366.
31. Boulting, G.L., Kiskinis, E., Croft, G.F., Amoroso, M.W., Oakley, D.H., Wainger, B.J., Williams, D.J., Kahler, D.J., Yamaki, M., Davidow, L., Rodolfa, C.T., Dimos, J.T., Mikkilineni, S., MacDermott, A.B., Woolf, C.J., Henderson, C.E., Wichterle, H., Eggan, K., A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29 (2011), 279–286.
32. Bouzier-Sore, A.K., Pellerin, L., Unraveling the complex metabolic nature of astrocytes. Front. Cell Neurosci., 7, 2013, 179.
33. Brenner, C., Moulin, M., Physiological roles of the permeability transition pore. Circ. Res. 111 (2012), 1237–1247.
34. Brewer, G.J., Espinosa, J., Mcilhaney, M.P., Pencek, T.P., Kesslak, J.P., Cotman, C., Viel, J., Mcmanus, D.C., Culture and regeneration of human neurons after brain surgery. J. Neurosci. Methods 107 (2001), 15–23.
35. Browne, S.E., Bowling, A.C., Macgarvey, U., Baik, M.J., Berger, S.C., Muqit, M.M., Bird, E.D., Beal, M.F., Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41 (1997), 646–653.
36. Bruck, W., The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J. Neurol., 252(Suppl. 5), 2005 v3–9.
37. Burchell, V.S., Nelson, D.E., Sanchez-Martinez, A., Delgado-Camprubi, M., Ivatt, R.M., Pogson, J.H., Randle, S.J., Wray, S., Lewis, P.A., Houlden, H., Abramov, A.Y., Hardy, J., Wood, N.W., Whitworth, A.J., Laman, H., Plun-Favreau, H., The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat. Neurosci. 16 (2013), 1257–1265.
38. Campbell, G.R., Worrall, J.T., Mahad, D.J., The central role of mitochondria in axonal degeneration in multiple sclerosis. Mult. Scler. 20 (2014), 1806–1813.
39. Campbell, G.R., Ziabreva, I., Reeve, A.K., Krishnan, K.J., Reynolds, R., Howell, O., Lassmann, H., Turnbull, D.M., Mahad, D.J., Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann. Neurol. 69 (2011), 481–492.
40. Carelli, V., D'adamo, P., Valentino, M.L., La Morgia, C., Ross-Cisneros, F.N., Caporali, L., Maresca, A., Loguercio Polosa, P., Barboni, P., De Negri, A., Sadun, F., Karanjia, R., Salomao, S.R., Berezovsky, A., Chicani, F., Moraes, M., Moraes Filho, M., Belfort, R. Jr., Sadun, A.A., Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion. Brain, 139, 2015, e17.
41. Carelli, V., La Morgia, C., Sadun, A.A., Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options. Curr. Opin. Neurol. 26 (2013), 52–58.
42. Carey, B.W., Finley, L.W., Cross, J.R., Allis, C.D., Thompson, C.B., Intracellular alpha-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518 (2015), 413–416.
43. Chambers, S.M., Fasano, C.A., Papapetrou, E.P., Tomishima, M., Sadelain, M., Studer, L., Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27 (2009), 275–280.
44. Chan, J.R., Watkins, T.A., Cosgaya, J.M., Zhang, C., Chen, L., Reichardt, L.F., Shooter, E.M., Barres, B.A., NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43 (2004), 183–191.
45. Charil, A., Dagher, A., Lerch, J.P., Zijdenbos, A.P., Worsley, K.J., Evans, A.C., Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage 34 (2007), 509–517.
46. Chen, W., Zhou, Z., Li, L., Zhong, C.Q., Zheng, X., Wu, X., Zhang, Y., Ma, H., Huang, D., Li, W., Xia, Z., Han, J., Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J. Biol. Chem. 288 (2013), 16247–16261.
47. Chen, Y., Balasubramaniyan, V., Peng, J., Hurlock, E.C., Tallquist, M., Li, J., Lu, Q.R., Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat. Protoc. 2 (2007), 1044–1051.
48. Chipuk, J.E., Moldoveanu, T., Llambi, F., Parsons, M.J., Green, D.R., The BCL-2 family reunion. Mol. Cell 37 (2010), 299–310.
49. Cho, I.H., Hong, J., Suh, E.C., Kim, J.H., Lee, H., Lee, J.E., Lee, S., Kim, C.H., Kim, D.W., Jo, E.K., Lee, K.E., Karin, M., Lee, S.J., Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death. Brain 131 (2008), 3019–3033.
50. Chora, A.A., Fontoura, P., Cunha, A., Pais, T.F., Cardoso, S., Ho, P.P., Lee, L.Y., Sobel, R.A., Steinman, L., Soares, M.P., Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 117 (2007), 438–447.
51. Compston, A., Coles, A., Multiple sclerosis. Lancet 359 (2002), 1221–1231.
52. Constantinescu, C.S., Farooqi, N., O'brien, K., Gran, B., Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164 (2011), 1079–1106.
53. Czepiel, M., Balasubramaniyan, V., Schaafsma, W., Stancic, M., Mikkers, H., Huisman, C., Boddeke, E., Copray, S., Differentiation of induced pluripotent stem cells into functional oligodendrocytes. Glia 59 (2011), 882–892.
54. Dantuma, N.P., Bott, L.C., The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution. Front. Mol. Neurosci., 7, 2014, 70.
55. Davis, C.W., Hawkins, B.J., Ramasamy, S., Irrinki, K.M., Cameron, B.A., Islam, K., Daswani, V.P., Doonan, P.J., Manevich, Y., Madesh, M., Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free Radic. Biol. Med. 48 (2010), 306–317.
56. De Groot, C.J., Langeveld, C.H., Jongenelen, C.A., Montagne, L., Van Der Valk, P., Dijkstra, C.D., Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J. Neurosci. Res. 49 (1997), 342–354.
57. De Stefani, D., Patron, M., Rizzuto, R., Structure and function of the mitochondrial calcium uniporter complex. Biochim. Biophys. Acta 1853 (2015), 2006–2011.
58. De Stefani, D., Raffaello, A., Teardo, E., Szabo, I., Rizzuto, R., A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476 (2011), 336–340.
59. Dienel, G.A., Cruz, N.F., Nutrition during brain activation: does cell-to-cell lactate shuttling contribute significantly to sweet and sour food for thought?. Neurochem. Int. 45 (2004), 321–351.
60. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R., Wichterle, H., Henderson, C.E., Eggan, K., Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321 (2008), 1218–1221.
61. Drexler, B., Hentschke, H., Antkowiak, B., Grasshoff, C., Organotypic cultures as tools for testing neuroactive drugs—link between in-vitro and in-vivo experiments. Curr. Med. Chem. 17 (2010), 4538–4550.
62. Douvaras, P., Fossati, V., Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells. Nat. Protoc. 10 (2015), 1143–1154.
63. Douvaras, P., Wang, J., Zimmer, M., Hanchuk, S., O'Bara, M.A., Sadiq, S., Sim, F.J., Goldman, J., Fossati, V., Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. Stem Cell Rep. 3 (2014), 250–259.
64. Druzhyna, N.M., Hollensworth, S.B., Kelley, M.R., Wilson, G.L., Ledoux, S.P., Targeting human 8-oxoguanine glycosylase to mitochondria of oligodendrocytes protects against menadione-induced oxidative stress. Glia 42 (2003), 370–378.
65. Druzhyna, N.M., Musiyenko, S.I., Wilson, G.L., Ledoux, S.P., Cytokines induce nitric oxide-mediated mtDNA damage and apoptosis in oligodendrocytes. Protective role of targeting 8-oxoguanine glycosylase to mitochondria. J. Biol. Chem. 280 (2005), 21673–21679.
66. Dyall, S.D., Brown, M.T., Johnson, P.J., Ancient invasions: from endosymbionts to organelles. Science 304 (2004), 253–257.
67. Eskelinen, E.L., New insights into the mechanisms of macroautophagy in mammalian cells. Int. Rev. Cell Mol. Biol. 266 (2008), 207–247.
68. Farooqi, N., Gran, B., Constantinescu, C.S., Are current disease-modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis?. J. Neurochem. 115 (2010), 829–844.
69. Fas, S.C., Fritzsching, B., Suri-Payer, E., Krammer, P.H., Death receptor signaling and its function in the immune system. Curr. Dir. Autoimmun. 9 (2006), 1–17.
70. Feng, Y., He, D., Yao, Z., Klionsky, D.J., The machinery of macroautophagy. Cell Res. 24 (2014), 24–41.
71. Filippi, M., Bozzali, M., Rovaris, M., Gonen, O., Kesavadas, C., Ghezzi, A., Martinelli, V., Grossman, R.I., Scotti, G., Comi, G., Falini, A., Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126 (2003), 433–437.
72. Fitzgerald, D.C., Ciric, B., Touil, T., Harle, H., Grammatikopolou, J., Das Sarma, J., Gran, B., Zhang, G.X., Rostami, A., Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 179 (2007), 3268–3275.
73. Foo, L.C., Purification and culture of astrocytes. Cold Spring Harb. Protoc. 2013 (2013), 485–487.
74. Forsby, A., Bal-Price, A.K., Camins, A., Coecke, S., Fabre, N., Gustafsson, H., Honegger, P., Kinsner-Ovaskainen, A., Pallas, M., Rimbau, V., Rodriguez-Farre, E., Sunol, C., Vericat, J.A., Zurich, M.G., Neuronal in vitro models for the estimation of acute systemic toxicity. Toxicol. In Vitro 23 (2009), 1564–1569.
75. Forte, M., Gold, B.G., Marracci, G., Chaudhary, P., Basso, E., Johnsen, D., Yu, X., Fowlkes, J., Rahder, M., Stem, K., Bernardi, P., Bourdette, D., Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 104 (2007), 7558–7563.
76. Franz, G., Beer, R., Intemann, D., Krajewski, S., Reed, J.C., Engelhardt, K., Pike, B.R., Hayes, R.L., Wang, K.K., Schmutzhard, E., Kampfl, A., Temporal and spatial profile of Bid cleavage after experimental traumatic brain injury. J. Cereb. Blood Flow. Metab. 22 (2002), 951–958.
77. French, H.M., Reid, M., Mamontov, P., Simmons, R.A., Grinspan, J.B., Oxidative stress disrupts oligodendrocyte maturation. J. Neurosci. Res. 87 (2009), 3076–3087.
78. Friese, M.A., Schattling, B., Fugger, L., Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat. Rev. Neurol. 10 (2014), 225–238.
79. Funfschilling, U., Supplie, L.M., Mahad, D., Boretius, S., Saab, A.S., Edgar, J., Brinkmann, B.G., Kassmann, C.M., Tzvetanova, I.D., Mobius, W., Diaz, F., Meijer, D., Suter, U., Hamprecht, B., Sereda, M.W., Moraes, C.T., Frahm, J., Goebbels, S., Nave, K.A., Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485 (2012), 517–521.
80. Galluzzi, L., Kepp, O., Kroemer, G., Mitochondrial regulation of cell death: a phylo-genetically conserved control. Microb. Cell 3 (2016), 101–108.
81. Galluzzi, L., Kroemer, G., Necroptosis turns TNF lethal. Immunity 35 (2011), 849–851.
82. Galluzzi, L., Vitale, I., Abrams, J.M., Alnemri, E.S., Baehrecke, E.H., Blagosklonny, M.V., Dawson, T.M., Dawson, V.L., El-Deiry, W.S., Fulda, S., Gottlieb, E., Green, D.R., Hengartner, M.O., Kepp, O., Knight, R.A., Kumar, S., Lipton, S.A., Lu, X., Madeo, F., Malorni, W., Mehlen, P., Nunez, G., Peter, M.E., Piacentini, M., Rubinsztein, D.C., Shi, Y., Simon, H.U., Vandenabeele, P., White, E., Yuan, J., Zhivotovsky, B., Melino, G., Kroemer, G., Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19 (2012), 107–120.
83. Geschwind, D.H., Miller, B.L., Molecular approaches to cerebral laterality: development and neurodegeneration. Am. J. Med. Genet. 101 (2001), 370–381.
84. Geurts, J.J., Barkhof, F., Grey matter pathology in multiple sclerosis. Lancet Neurol. 7 (2008), 841–851.
85. Giorgi, C., Baldassari, F., Bononi, A., Bonora, M., De Marchi, E., Marchi, S., Missiroli, S., Patergnani, S., Rimessi, A., Suski, J.M., Wieckowski, M.R., Pinton, P., Mitochondrial Ca(2+) and apoptosis. Cell Calcium 52 (2012), 36–43.
86. Giorgi, C., Ito, K., Lin, H.K., Santangelo, C., Wieckowski, M.R., Lebiedzinska, M., Bononi, A., Bonora, M., Duszynski, J., Bernardi, R., Rizzuto, R., Tacchetti, C., Pinton, P., Pandolfi, P.P., PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 330 (2010), 1247–1251.
87. Gogolla, N., Galimberti, I., Depaola, V., Caroni, P., Preparation of organotypic hippocampal slice cultures for long-term live imaging. Nat. Protoc. 1 (2006), 1165–1171.
88. Goldman, S.A., Kuypers, N.J., How to make an oligodendrocyte. Development 142 (2015), 3983–3995.
89. Gonsette, R.E., Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?. Mult. Scler. 14 (2008), 22–34.
90. Gordon, J., Amini, S., White, M.K., General overview of neuronal cell culture. Methods Mol. Biol. 1078 (2013), 1–8.
91. Grander, D., Kharaziha, P., Laane, E., Pokrovskaja, K., Panaretakis, T., Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies. Autophagy 5 (2009), 1198–1200.
92. Gruber, R.C., Larocca, D., Minchenberg, S.B., Christophi, G.P., Hudson, C.A., Ray, A.K., Shafit-Zagardo, B., Massa, P.T., The control of reactive oxygen species production by SHP-1 in oligodendrocytes. Glia 63 (2015), 1753–1771.
93. Gurok, U., Steinhoff, C., Lipkowitz, B., Ropers, H.H., Scharff, C., Nuber, U.A., Gene expression changes in the course of neural progenitor cell differentiation. J. Neurosci. 24 (2004), 5982–6002.
94. Guy, J., Ellis, E.A., Hope, G.M., Rao, N.A., Antioxidant enzymes reduce loss of blood-brain barrier integrity in experimental optic neuritis. Arch. Ophthalmol. 107 (1989), 1359–1363.
95. Halestrap, A.P., What is the mitochondrial permeability transition pore?. J. Mol. Cell. Cardiol. 46 (2009), 821–831.
96. Halestrap, A.P., The C Ring of the F1Fo ATP Synthase Forms the Mitochondrial Permeability Transition Pore: A Critical Appraisal. Front. Oncol., 4, 2014, 234.
97. Hall, C.N., Klein-Flugge, M.C., Howarth, C., Attwell, D., Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing. J. Neurosci. 32 (2012), 8940–8951.
98. Hametner, S., Wimmer, I., Haider, L., Pfeifenbring, S., Bruck, W., Lassmann, H., Iron and neurodegeneration in the multiple sclerosis brain. Ann. Neurol. 74 (2013), 848–861.
99. Hargus, G., Cooper, O., Deleidi, M., Levy, A., Lee, K., Marlow, E., Yow, A., Soldner, F., Hockemeyer, D., Hallett, P.J., Osborn, T., Jaenisch, R., Isacson, O., Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. Acad. Sci. USA 107 (2010), 15921–15926.
100. Harris, J.J., Jolivet, R., Attwell, D., Synaptic energy use and supply. Neuron 75 (2012), 762–777.
101. He, F., Sun, Y.E., Glial cells more than support cells?. Int. J. Biochem. Cell Biol. 39 (2007), 661–665.
102. He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., Wang, X., Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137 (2009), 1100–1111.
103. Hebb, A.L., Moore, C.S., Bhan, V., Robertson, G.S., Targeting apoptosis to treat multiple sclerosis. Curr. Drug Discov. Technol. 5 (2008), 75–77.
104. Hendriks, J.J., Alblas, J., Van Der Pol, S.M., Van Tol, E.A., Dijkstra, C.D., De Vries, H.E., Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J. Exp. Med. 200 (2004), 1667–1672.
105. Hisahara, S., Araki, T., Sugiyama, F., Yagami, K., Suzuki, M., Abe, K., Yamamura, K., Miyazaki, J., Momoi, T., Saruta, T., Bernard, C.C., Okano, H., Miura, M., Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J. 19 (2000), 341–348.
106. Hisahara, S., Shoji, S., Okano, H., Miura, M., ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J. Neurochem. 69 (1997), 10–20.
107. Holley, J.E., Newcombe, J., Winyard, P.G., Gutowski, N.J., Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes. Mult. Scler. 13 (2007), 955–961.
108. Homem, C.C., Steinmann, V., Burkard, T.R., Jais, A., Esterbauer, H., Knoblich, J.A., Ecdysone and mediator change energy metabolism to terminate proliferation in Drosophila neural stem cells. Cell 158 (2014), 874–888.
109. Hovelmeyer, N., Hao, Z., Kranidioti, K., Kassiotis, G., Buch, T., Frommer, F., Von Hoch, L., Kramer, D., Minichiello, L., Kollias, G., Lassmann, H., Waisman, A., Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005), 5875–5884.
110. Hung, S.Y., Liou, H.C., Kang, K.H., Wu, R.M., Wen, C.C., Fu, W.M., Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol. Pharmacol. 74 (2008), 1564–1575.
111. Hwang, K.E., Kim, Y.S., Jung, J.W., Kwon, S.J., Park, D.S., Cha, B.K., Oh, S.H., Yoon, K.H., Jeong, E.T., Kim, H.R., Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells. Oncotarget 6 (2015), 29482–29496.
112. Itoh, K., Culture of oligodendrocyte precursor cells (NG2(+)/O1(-)) and oligodendrocytes (NG2(-)/O1(+)) from embryonic rat cerebrum. Brain Res. Brain Res. Protoc. 10 (2002), 23–30.
113. Itoh, K., Kawamura, H., Asou, H., A novel monoclonal antibody against carbohydrates of L1 cell adhesion molecule causes an influx of calcium in cultured cortical neurons. Brain Res. 580 (1992), 233–240.
114. Jiang, P.C., Xiong, W.P., Wang, G., Ma, C., Yao, W.Q., Kendell, S.F., Mehling, B.M., Yuan, X.H., Wu, D.C., A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury. Exp. Ther. Med. 6 (2013), 140–146.
115. Jiang, P., Mizushima, N., Autophagy and human diseases. Cell Res. 24 (2014), 69–79.
116. Kalman, B., Laitinen, K., Komoly, S., The involvement of mitochondria in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 188 (2007), 1–12.
117. Kappos, L., Hartung, H.P., Freedman, M.S., Boyko, A., Radu, E.W., Mikol, D.D., Lamarine, M., Hyvert, Y., Freudensprung, U., Plitz, T., Van Beek, J., Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. Lancet Neurol. 13 (2014), 353–363.
118. Kean, R.B., Spitsin, S.V., Mikheeva, T., Scott, G.S., Hooper, D.C., The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity. J. Immunol. 165 (2000), 6511–6518.
119. Kelly, D.P., Scarpulla, R.C., Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18 (2004), 357–368.
120. Kihara, A., Kabeya, Y., Ohsumi, Y., Yoshimori, T., Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2 (2001), 330–335.
121. Kim, S.R., Chen, X., Oo, T.F., Kareva, T., Yarygina, O., Wang, C., During, M., Kholodilov, N., Burke, R.E., Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration. Ann. Neurol. 70 (2011), 110–120.
122. Kipp, M., Clarner, T., Dang, J., Copray, S., Beyer, C., The cuprizone animal model: new insights into an old story. Acta Neuropathol. 118 (2009), 723–736.
123. Kitazawa, A., Shimizu, N., Differentiation of mouse embryonic stem cells into neurons using conditioned medium of dorsal root ganglia. J. Biosci. Bioeng. 100 (2005), 94–99.
124. Klionsky, D.J., Abdelmohsen, K., Abe, A., Abedin, M.J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C.M., Adams, P.D., Adeli, K., Adhihetty, P.J., Adler, S.G., Agam, G., Agarwal, R., Aghi, M.K., Agnello, M., Agostinis, P., Aguilar, P.V., Aguirre-Ghiso, J., Airoldi, E.M., Ait-Si-Ali, S., Akematsu, T., Akporiaye, E.T., Al-Rubeai, M., Albaiceta, G.M., Albanese, C., Albani, D., Albert, M.L., Aldudo, J., Algul, H., Alirezaei, M., Alloza, I., Almasan, A., Almonte-Beceril, M., Alnemri, E.S., Alonso, C., Altan-Bonnet, N., Altieri, D.C., Alvarez, S., Alvarez-Erviti, L., Alves, S., Amadoro, G., Amano, A., Amantini, C., Ambrosio, S., Amelio, I., Amer, A.O., Amessou, M., Amon, A., An, Z., Anania, F.A., Andersen, S.U., Andley, U.P., Andreadi, C.K., Andrieu-Abadie, N., Anel, A., Ann, D.K., Anoopkumar-Dukie, S., Antonioli, M., Aoki, H., Apostolova, N., Aquila, S., Aquilano, K., Araki, K., Arama, E., Aranda, A., Araya, J., Arcaro, A., Arias, E., Arimoto, H., Ariosa, A.R., Armstrong, J.L., Arnould, T., Arsov, I., Asanuma, K., Askanas, V., Asselin, E., Atarashi, R., Atherton, S.S., Atkin, J.D., Attardi, L.D., Auberger, P., Auburger, G., Aurelian, L., Autelli, R., Avagliano, L., Avantaggiati, M.L., Avrahami, L., Awale, S., Azad, N., Bachetti, T., Backer, J.M., Bae, D.H., Bae, J.S., Bae, O.N., Bae, S.H., Baehrecke, E.H., Baek, S.H., Baghdiguian, S., Bagniewska-Zadworna, A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12 (2016), 1–222.
125. Koopman, W.J., Distelmaier, F., Smeitink, J.A., Willems, P.H., OXPHOS mutations and neurodegeneration. EMBO J. 32 (2013), 9–29.
126. Kornek, B., Storch, M.K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., Lassmann, H., Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157 (2000), 267–276.
127. Krencik, R., Zhang, S.C., Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat. Protoc. 6 (2011), 1710–1717.
128. Kroemer, G., Galluzzi, L., Brenner, C., Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87 (2007), 99–163.
129. Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E.S., Baehrecke, E.H., Blagosklonny, M.V., El-Deiry, W.S., Golstein, P., Green, D.R., Hengartner, M., Knight, R.A., Kumar, S., Lipton, S.A., Malorni, W., Nunez, G., Peter, M.E., Tschopp, J., Yuan, J., Piacentini, M., Zhivotovsky, B., Melino, G., Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 16 (2009), 3–11.
130. Kuhlmann, T., Lassmann, H., Bruck, W., Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol. 115 (2008), 275–287.
131. Landgrave-Gomez, J., Mercado-Gomez, O., Guevara-Guzman, R., Epigenetic mechanisms in neurological and neurodegenerative diseases. Front. Cell Neurosci., 9, 2015, 58.
132. Lassmann, H., van Horssen, J., Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions. Biochim. Biophys. Acta 1862 (2016), 506–510.
133. Lee, G., Kim, H., Elkabetz, Y., Al Shamy, G., Panagiotakos, G., Barberi, T., Tabar, V., Studer, L., Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat. Biotechnol. 25 (2007), 1468–1475.
134. Lee, Y., Morrison, B.M., Li, Y., Lengacher, S., Farah, M.H., Hoffman, P.N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.W., Pellerin, L., Magistretti, P.J., Rothstein, J.D., Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487 (2012), 443–448.
135. Lenaz, G., Baracca, A., Carelli, V., D'aurelio, M., Sgarbi, G., Solaini, G., Bioenergetics of mitochondrial diseases associated with mtDNA mutations. Biochim. Biophys. Acta 1658 (2004), 89–94.
136. Levine, B., Klionsky, D.J., Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6 (2004), 463–477.
137. Li, C., Capan, E., Zhao, Y., Zhao, J., Stolz, D., Watkins, S.C., Jin, S., Lu, B., Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. J. Immunol. 177 (2006), 5163–5168.
138. Li, H., Zhu, H., Xu, C.J., Yuan, J., Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94 (1998), 491–501.
139. Li, J., Johnson, D., Calkins, M., Wright, L., Svendsen, C., Johnson, J., Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol. Sci. 83 (2005), 313–328.
140. Lin, A.L., Fox, P.T., Hardies, J., Duong, T.Q., Gao, J.H., Nonlinear coupling between cerebral blood flow, oxygen consumption, and ATP production in human visual cortex. Proc. Natl. Acad. Sci. USA 107 (2010), 8446–8451.
141. Lin, M.T., Beal, M.F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006), 787–795.
142. Lindberg, R.L., De Groot, C.J., Certa, U., Ravid, R., Hoffmann, F., Kappos, L., Leppert, D., Multiple sclerosis as a generalized CNS disease—comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. J. Neuroimmunol. 152 (2004), 154–167.
143. Linkermann, A., Brasen, J.H., De Zen, F., Weinlich, R., Schwendener, R.A., Green, D.R., Kunzendorf, U., Krautwald, S., Dichotomy between RIP1- and RIP3-mediated necroptosis in tumor necrosis factor-alpha-induced shock. Mol. Med. 18 (2012), 577–586.
144. Liu, Y., Liu, J., Tetzlaff, W., Paty, D.W., Cynader, M.S., Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis. Free Radic. Biol. Med. 40 (2006), 960–967.
145. Liu, Y., Zhu, B., Wang, X., Luo, L., Li, P., Paty, D.W., Cynader, M.S., Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. J. Neuroimmunol. 139 (2003), 27–35.
146. Lombes, A., Nakase, H., Tritschler, H.J., Kadenbach, B., Bonilla, E., Devivo, D.C., Schon, E.A., Dimauro, S., Biochemical and molecular analysis of cytochrome c oxidase deficiency in Leigh's syndrome. Neurology 41 (1991), 491–498.
147. Lu, B., Capan, E., Li, C., Autophagy induction and autophagic cell death in effector T cells. Autophagy 3 (2007), 158–159.
148. Lu, F., Selak, M., O'connor, J., Croul, S., Lorenzana, C., Butunoi, C., Kalman, B., Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177 (2000), 95–103.
149. Lubetzki, C., Demerens, C., Anglade, P., Villarroya, H., Frankfurter, A., Lee, V.M., Zalc, B., Even in culture, oligodendrocytes myelinate solely axons. Proc. Natl. Acad. Sci. USA 90 (1993), 6820–6824.
150. Lucchinetti, C., Bruck, W., The pathology of primary progressive multiple sclerosis. Mult. Scler. 10:Suppl. 1 (2004), S23–S30.
151. Lucchinetti, C.F., Parisi, J., Bruck, W., The pathology of multiple sclerosis. Neurol. Clin. 23 (2005), 77–105 vi.
152. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., Wang, X., Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998), 481–490.
153. Macchi, B., Marino-Merlo, F., Nocentini, U., Pisani, V., Cuzzocrea, S., Grelli, S., Mastino, A., Role of inflammation and apoptosis in multiple sclerosis: comparative analysis between the periphery and the central nervous system. J. Neuroimmunol. 287 (2015), 80–87.
154. Madeira, V.M., Overview of mitochondrial bioenergetics. Methods Mol. Biol. 810 (2012), 1–6.
155. Mahad, D., Lassmann, H., Turnbull, D., Review: Mitochondria and disease progression in multiple sclerosis. Neuropathol. Appl. Neurobiol. 34 (2008), 577–589.
156. Mahad, D., Ziabreva, I., Lassmann, H., Turnbull, D., Mitochondrial defects in acute multiple sclerosis lesions. Brain 131 (2008), 1722–1735.
157. Mahad, D.H., Trapp, B.D., Lassmann, H., Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 14 (2015), 183–193.
158. Maiuri, M.C., Criollo, A., Tasdemir, E., Vicencio, J.M., Tajeddine, N., Hickman, J.A., Geneste, O., Kroemer, G., BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 3 (2007), 374–376.
159. Manfredonia, F., Ciccarelli, O., Khaleeli, Z., Tozer, D.J., Sastre-Garriga, J., Miller, D.H., Thompson, A.J., Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis. Arch. Neurol. 64 (2007), 411–415.
160. Mao, P., Reddy, P.H., Is multiple sclerosis a mitochondrial disease?. Biochim. Biophys. Acta 1802 (2010), 66–79.
161. Marchi, S., Pinton, P., The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications. J. Physiol. 592 (2014), 829–839.
162. 2+-dependent apoptotic stimuli. Biochem. Biophys. Res. Commun. 375 (2008), 501–505.
163. Matsushima, G.K., Morell, P., The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11 (2001), 107–116.
164. Mattiazzi, M., D'aurelio, M., Gajewski, C.D., Martushova, K., Kiaei, M., Beal, M.F., Manfredi, G., Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 277 (2002), 29626–29633.
165. McCarthy, D.P., Richards, M.H., Miller, S.D., Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods Mol. Biol. 900 (2012), 381–401.
166. McKinnon, C., Tabrizi, S.J., The ubiquitin-proteasome system in neurodegeneration. Antioxid. Redox Signal. 21 (2014), 2302–2321.
167. Medina-Rodriguez, E.M., Arenzana, F.J., Bribian, A., De Castro, F., Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans. PLoS ONE, 8, 2013, e81620.
168. Merkle, F.T., Neuhausser, W.M., Santos, D., Valen, E., Gagnon, J.A., Maas, K., Sandoe, J., Schier, A.F., Eggan, K., Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Cell Rep. 11 (2015), 875–883.
169. Merrill, J.E., Ignarro, L.J., Sherman, M.P., Melinek, J., Lane, T.E., Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151 (1993), 2132–2141.
170. Merrill, J.E., Scolding, N.J., Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol. Appl. Neurobiol. 25 (1999), 435–458.
171. Mews, I., Bergmann, M., Bunkowski, S., Gullotta, F., Bruck, W., Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult. Scler. 4 (1998), 55–62.
172. Mi, S., Miller, R.H., Tang, W., Lee, X., Hu, B., Wu, W., Zhang, Y., Shields, C.B., Miklasz, S., Shea, D., Mason, J., Franklin, R.J., Ji, B., Shao, Z., Chedotal, A., Bernard, F., Roulois, A., Xu, J., Jung, V., Pepinsky, B., Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann. Neurol. 65 (2009), 304–315.
173. Ming, G.L., Song, H., Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 28 (2005), 223–250.
174. Mink, J.W., Blumenschine, R.J., Adams, D.B., Ratio of central nervous system to body metabolism in vertebrates: its constancy and functional basis. Am. J. Physiol. 241 (1981), R203–R212.
175. Mizushima, N., Komatsu, M., Autophagy: renovation of cells and tissues. Cell 147 (2011), 728–741.
176. Morciano, G., Giorgi, C., Balestra, D., Marchi, S., Perrone, D., Pinotti, M., Pinton, P., Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death. Mol. Biol. Cell 27 (2016), 20–34.
177. Morciano, G., Giorgi, C., Bonora, M., Punzetti, S., Pavasini, R., Wieckowski, M.R., Campo, G., Pinton, P., Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury. J. Mol. Cell Cardiol. 78 (2015), 142–153.
178. Moriwaki, K., Farias Luz, N., Balaji, S., De Rosa, M.J., O'donnell, C.L., Gough, P.J., Bertin, J., Welsh, R.M., Chan, F.K., The mitochondrial phosphatase PGAM5 is dispensable for necroptosis but promotes inflammasome activation in macrophages. J. Immunol. 196 (2016), 407–415.
179. Moriya, M., Nakatsuji, Y., Miyamoto, K., Okuno, T., Kinoshita, M., Kumanogoh, A., Kusunoki, S., Sakoda, S., Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis. Neurosci. Lett. 440 (2008), 323–326.
180. Moubarak, R.S., Yuste, V.J., Artus, C., Bouharrour, A., Greer, P.A., Menissier-De Murcia, J., Susin, S.A., Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. Mol. Cell Biol. 27 (2007), 4844–4862.
181. Munoz-Fernandez, M.A., Fresno, M., The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56 (1998), 307–340.
182. Muthuswamy, S., Agarwal, S., Friedreich ataxia: from the eye of a molecular biologist. Neurologist 20 (2015), 51–55.
183. Muzio, M., Chinnaiyan, A.M., Kischkel, F.C., O'rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., Mann, M., Krammer, P.H., Peter, M.E., Dixit, V.M., FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death—inducing signaling complex. Cell 85 (1996), 817–827.
184. Nair, A., Frederick, T.J., Miller, S.D., Astrocytes in multiple sclerosis: a product of their environment. Cell Mol. Life Sci. 65 (2008), 2702–2720.
185. Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.F., Gautier, C.A., Shen, J., Cookson, M.R., Youle, R.J., PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8, 2010, e1000298.
186. Nijland, P.G., Witte, M.E., Van Het Hof, B., Van Der Pol, S., Bauer, J., Lassmann, H., Van Der Valk, P., De Vries, H.E., Van Horssen, J., Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis. Acta Neuropathol. Commun., 2, 2014, 170.
187. Nylander, A., Hafler, D.A., Multiple sclerosis. J. Clin. Invest. 122 (2012), 1180–1188.
188. Okuda, Y., Apatoff, B.R., Posnett, D.N., Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis. J. Neuroimmunol. 171 (2006), 163–170.
189. Paglin, S., Lee, N.Y., Nakar, C., Fitzgerald, M., Plotkin, J., Deuel, B., Hackett, N., Mcmahill, M., Sphicas, E., Lampen, N., Yahalom, J., Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Res. 65 (2005), 11061–11070.
190. Palikaras, K., Tavernarakis, N., Mitophagy in neurodegeneration and aging. Front. Genet., 3, 2012, 297.
191. Pandit, A., Vadnal, J., Houston, S., Freeman, E., Mcdonough, J., Impaired regulation of electron transport chain subunit genes by nuclear respiratory factor 2 in multiple sclerosis. J. Neurol. Sci. 279 (2009), 14–20.
192. Park, K.K., Liu, K., Hu, Y., Smith, P.D., Wang, C., Cai, B., Xu, B., Connolly, L., Kramvis, I., Sahin, M., He, Z., Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322 (2008), 963–966.
193. Pasquini, L.A., Calatayud, C.A., Bertone Una, A.L., Millet, V., Pasquini, J.M., Soto, E.F., The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem. Res. 32 (2007), 279–292.
194. Patel, A.B., Lai, J.C., Chowdhury, G.M., Hyder, F., Rothman, D.L., Shulman, R.G., Behar, K.L., Direct evidence for activity-dependent glucose phosphorylation in neurons with implications for the astrocyte-to-neuron lactate shuttle. Proc. Natl. Acad. Sci. USA 111 (2014), 5385–5390.
195. Patergnani, S., Marchi, S., Rimessi, A., Bonora, M., Giorgi, C., Mehta, K.D., Pinton, P., PRKCB/protein kinase C, beta and the mitochondrial axis as key regulators of autophagy. Autophagy 9 (2013), 1367–1385.
196. Patergnani, S., Pinton, P., Mitophagy and mitochondrial balance. Methods Mol. Biol. 1241 (2015), 181–194.
197. Patergnani, S., Suski, J.M., Agnoletto, C., Bononi, A., Bonora, M., De Marchi, E., Giorgi, C., Marchi, S., Missiroli, S., Poletti, F., Rimessi, A., Duszynski, J., Wieckowski, M.R., Pinton, P., Calcium signaling around Mitochondria Associated Membranes (MAMs). Cell Commun. Signal., 9, 2011, 19.
198. Pathak, D., Shields, L.Y., Mendelsohn, B.A., Haddad, D., Lin, W., Gerencser, A.A., Kim, H., Brand, M.D., Edwards, R.H., Nakamura, K., The role of mitochondrially derived ATP in synaptic vesicle recycling. J. Biol. Chem. 290 (2015), 22325–22336.
199. Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M., Schneider, M.D., Levine, B., Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005), 927–939.
200. Pinton, P., Ferrari, D., Magalhaes, P., Schulze-Osthoff, K., Di Virgilio, F., Pozzan, T., Rizzuto, R., Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J. Cell Biol. 148 (2000), 857–862.
201. 2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J. 20 (2001), 2690–2701.
202. Plaisant, F., Clippe, A., Vander Stricht, D., Knoops, B., Gressens, P., Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice. Free Radic. Biol. Med. 34 (2003), 862–872.
203. Pleasure, S.J., Page, C., Lee, V.M., Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12 (1992), 1802–1815.
204. Pouly, S., Becher, B., Blain, M., Antel, J.P., Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J. Neuropathol. Exp. Neurol. 59 (2000), 280–286.
205. Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R.C., Melton, D.A., “Stemness”: transcriptional profiling of embryonic and adult stem cells. Science 298 (2002), 597–600.
206. Ramanathan, A., Schreiber, S.L., Direct control of mitochondrial function by mTOR. Proc. Natl. Acad. Sci. USA 106 (2009), 22229–22232.
207. Ransohoff, R.M., Hafler, D.A., Lucchinetti, C.F., Multiple sclerosis-a quiet revolution. Nat. Rev. Neurol. 11 (2015), 134–142.
208. 2+ signals as causes or consequences of mitophagy induction. Autophagy 9 (2013), 1677–1686.
209. Rimessi, A., Marchi, S., Fotino, C., Romagnoli, A., Huebner, K., Croce, C.M., Pinton, P., Rizzuto, R., Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis. Proc. Natl. Acad. Sci. USA 106 (2009), 12753–12758.
210. Rinholm, J.E., Hamilton, N.B., Kessaris, N., Richardson, W.D., Bergersen, L.H., Attwell, D., Regulation of oligodendrocyte development and myelination by glucose and lactate. J. Neurosci. 31 (2011), 538–548.
211. 2+ responses. Science 280 (1998), 1763–1766.
212. Rone, M.B., Cui, Q.L., Fang, J., Wang, L.C., Zhang, J., Khan, D., Bedard, M., Almazan, G., Ludwin, S.K., Jones, R., Kennedy, T.E., Antel, J.P., Oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival. J. Neurosci. 36 (2016), 4698–4707.
213. Rosen, D.R., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 364, 1993, 362.
214. Rovaris, M., Judica, E., Gallo, A., Benedetti, B., Sormani, M.P., Caputo, D., Ghezzi, A., Montanari, E., Bertolotto, A., Mancardi, G., Bergamaschi, R., Martinelli, V., Comi, G., Filippi, M., Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 129 (2006), 2628–2634.
215. Ruuls, S.R., Bauer, J., Sontrop, K., Huitinga, I., ’t Hart, B.A., Dijkstra, C.D., Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 56 (1995), 207–217.
216. Ryan, B.J., Hoek, S., Fon, E.A., Wade-Martins, R., Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease. Trends Biochem. Sci. 40 (2015), 200–210.
217. Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., Debatin, K.M., Krammer, P.H., Peter, M.E., Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17 (1998), 1675–1687.
218. Scarpulla, R.C., Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88 (2008), 611–638.
219. Schattling, B., Steinbach, K., Thies, E., Kruse, M., Menigoz, A., Ufer, F., Flockerzi, V., Bruck, W., Pongs, O., Vennekens, R., Kneussel, M., Freichel, M., Merkler, D., Friese, M.A., TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 18 (2012), 1805–1811.
220. Schieke, S.M., Phillips, D., McCoy, J.P. Jr., Aponte, A.M., Shen, R.F., Balaban, R.S., Finkel, T., The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 281 (2006), 27643–27652.
221. Schildge, S., Bohrer, C., Beck, K., Schachtrup, C., Isolation and culture of mouse cortical astrocytes. J. Vis. Exp., 71, 2013, e50079.
222. Schoenfeld, R., Wong, A., Silva, J., Li, M., Itoh, A., Horiuchi, M., Itoh, T., Pleasure, D., Cortopassi, G., Oligodendroglial differentiation induces mitochondrial genes and inhibition of mitochondrial function represses oligodendroglial differentiation. Mitochondrion 10 (2010), 143–150.
223. Schon, E.A., Manfredi, G., Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest. 111 (2003), 303–312.
224. Scurlock, B., Dawson, G., Differential responses of oligodendrocytes to tumor necrosis factor and other pro-apoptotic agents: role of ceramide in apoptosis. J. Neurosci. Res. 55 (1999), 514–522.
225. Segal, B.M., Constantinescu, C.S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., Kasper, L.H., Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol. 7 (2008), 796–804.
226. Shaltouki, A., Peng, J., Liu, Q., Rao, M.S., Zeng, X., Efficient generation of astrocytes from human pluripotent stem cells in defined conditions. Stem Cells 31 (2013), 941–952.
227. Sharif, A., Prevot, V., Isolation and culture of human astrocytes. Methods Mol. Biol. 814 (2012), 137–151.
228. Shen, S., Kepp, O., Kroemer, G., The end of autophagic cell death?. Autophagy 8 (2012), 1–3.
229. Shen, S., Kepp, O., Michaud, M., Martins, I., Minoux, H., Metivier, D., Maiuri, M.C., Kroemer, R.T., Kroemer, G., Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 30 (2011), 4544–4556.
230. Shi, Y., Wei, L., Wang, Y., Ren, G., Stem cells deployed for bone repair hijacked by T cells. Cell Stem Cell 10 (2012), 6–8.
231. Shintani, T., Klionsky, D.J., Autophagy in health and disease: a double-edged sword. Science 306 (2004), 990–995.
232. Skaper, S.D., Argentini, C., Barbierato, M., Culture of neonatal rodent microglia, astrocytes, and oligodendrocytes from cortex and spinal cord. Methods Mol. Biol. 846 (2012), 67–77.
233. Skripuletz, T., Lindner, M., Kotsiari, A., Garde, N., Fokuhl, J., Linsmeier, F., Trebst, C., Stangel, M., Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 172 (2008), 1053–1061.
234. Smith, A.M., Sanchez, M.J., Follows, G.A., Kinston, S., Donaldson, I.J., Green, A.R., Gottgens, B., A novel mode of enhancer evolution: the Tal1 stem cell enhancer recruited a MIR element to specifically boost its activity. Genome Res. 18 (2008), 1422–1432.
235. Soliven, B., Takeda, M., Szuchet, S., Depolarizing agents and tumor necrosis factor-alpha modulate protein phosphorylation in oligodendrocytes. J. Neurosci. Res. 38 (1994), 91–100.
236. Stadelmann, C., Albert, M., Wegner, C., Bruck, W., Cortical pathology in multiple sclerosis. Curr. Opin. Neurol. 21 (2008), 229–234.
237. Stys, P.K., Zamponi, G.W., Van Minnen, J., Geurts, J.J., Will the real multiple sclerosis please stand up?. Nat. Rev. Neurosci. 13 (2012), 507–514.
238. Su, K.G., Savino, C., Marracci, G., Chaudhary, P., Yu, X., Morris, B., Galipeau, D., Giorgio, M., Forte, M., Bourdette, D., Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of multiple sclerosis. Eur. J. Neurosci. 35 (2012), 562–571.
239. Subramaniam, S.R., Chesselet, M.F., Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Prog. Neurobiol. 106–107 (2013), 17–32.
240. Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., Wang, X., Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148 (2012), 213–227.
241. Tabrizi, S.J., Cleeter, M.W., Xuereb, J., Taanman, J.W., Cooper, J.M., Schapira, A.H., Biochemical abnormalities and excitotoxicity in Huntington's disease brain. Ann. Neurol. 45 (1999), 25–32.
242. Tajouri, L., Mellick, A.S., Ashton, K.J., Tannenberg, A.E., Nagra, R.M., Tourtellotte, W.W., Griffiths, L.R., Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis. Brain Res. Mol. Brain Res. 119 (2003), 170–183.
243. Takata, K., Kitamura, Y., Kakimura, J., Shibagaki, K., Taniguchi, T., Gebicke-Haerter, P.J., Smith, M.A., Perry, G., Shimohama, S., Possible protective mechanisms of heme oxygenase-1 in the brain. Ann. N. Y. Acad. Sci. 977 (2002), 501–506.
244. Tan, W., Pasinelli, P., Trotti, D., Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1842 (2014), 1295–1301.
245. Temkin, V., Huang, Q., Liu, H., Osada, H., Pope, R.M., Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol. Cell Biol. 26 (2006), 2215–2225.
246. Torkildsen, O., Brunborg, L.A., Myhr, K.M., Bo, L., The cuprizone model for demyelination. Acta Neurol. Scand. Suppl. 188 (2008), 72–76.
247. Tracy, E.T., Zhang, C.Y., Gentry, T., Shoulars, K.W., Kurtzberg, J., Isolation and expansion of oligodendrocyte progenitor cells from cryopreserved human umbilical cord blood. Cytotherapy 13 (2011), 722–729.
248. Trapp, B.D., Peterson, J., Ransohoff, R.M., Rudick, R., Mork, S., Bo, L., Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998), 278–285.
249. Trapp, B.D., Stys, P.K., Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 8 (2009), 280–291.
250. Trotter, J., The development of myelin-forming glia: studies with primary cell cultures and immortalized cell lines. Perspect. Dev. Neurobiol. 1 (1993), 149–154.
251. Tyler, W.A., Gangoli, N., Gokina, P., Kim, H.A., Covey, M., Levison, S.W., Wood, T.L., Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J. Neurosci. 29 (2009), 6367–6378.
252. van der Star, B.J., Vogel, D.Y., Kipp, M., Puentes, F., Baker, D., Amor, S., In vitro and in vivo models of multiple sclerosis. CNS Neurol. Disord. Drug Targets 11 (2012), 570–588.
253. van Horssen, J., Schreibelt, G., Bo, L., Montagne, L., Drukarch, B., Van Muiswinkel, F.L., De Vries, H.E., NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. Free Radic. Biol. Med. 41 (2006), 311–317.
254. van Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C.D., Van Der Valk, P., De Vries, H.E., Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic. Biol. Med. 45 (2008), 1729–1737.
255. van Horssen, J., Witte, M.E., Schreibelt, G., De Vries, H.E., Radical changes in multiple sclerosis pathogenesis. Biochim. Biophys. Acta 1812 (2011), 141–150.
256. van Oosten, B.W., Barkhof, F., Truyen, L., Boringa, J.B., Bertelsmann, F.W., Von Blomberg, B.M., Woody, J.N., Hartung, H.P., Polman, C.H., Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47 (1996), 1531–1534.
257. Vanderlugt, C.L., Rahbe, S.M., Elliott, P.J., Dal Canto, M.C., Miller, S.D., Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. J. Autoimmun. 14 (2000), 205–211.
258. Vartanian, T., Li, Y., Zhao, M., Stefansson, K., Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1 (1995), 732–743.
259. Verwer, R.W., Hermens, W.T., Dijkhuizen, P., Ter Brake, O., Baker, R.E., Salehi, A., Sluiter, A.A., Kok, M.J., Muller, L.J., Verhaagen, J., Swaab, D.F., Cells in human postmortem brain tissue slices remain alive for several weeks in culture. FASEB J. 16 (2002), 54–60.
260. Vogel, F., Bornhovd, C., Neupert, W., Reichert, A.S., Dynamic subcompartmentalization of the mitochondrial inner membrane. J. Cell Biol. 175 (2006), 237–247.
261. Vogler, S., Goedde, R., Miterski, B., Gold, R., Kroner, A., Koczan, D., Zettl, U.K., Rieckmann, P., Epplen, J.T., Ibrahim, S.M., Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis. J. Mol. Med. (Berl.) 83 (2005), 806–811.
262. Volgyi, K., Gulyassy, P., Haden, K., Kis, V., Badics, K., Kekesi, K.A., Simor, A., Gyorffy, B., Toth, E.A., Lubec, G., Juhasz, G., Dobolyi, A., Synaptic mitochondria: a brain mitochondria cluster with a specific proteome. J. Proteomics 120 (2015), 142–157.
263. Wang, C., Fong, H., Huang, Y., Direct reprogramming of RESTing astrocytes. Cell Stem Cell 17 (2015), 1–3.
264. Wang, H., Tewari, A., Einheber, S., Salzer, J.L., Melendez-Vasquez, C.V., Myosin II has distinct functions in PNS and CNS myelin sheath formation. J. Cell Biol. 182 (2008), 1171–1184.
265. Watkins, T.A., Emery, B., Mulinyawe, S., Barres, B.A., Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 60 (2008), 555–569.
266. Waxman, S.G., Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status. Nat. Clin. Pract. Neurol. 4 (2008), 159–169.
267. Werner, P., Pitt, D., Raine, C.S., Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50 (2001), 169–180.
268. Wilhelmus, M.M., Van Der Pol, S.M., Jansen, Q., Witte, M.E., Van Der Valk, P., Rozemuller, A.J., Drukarch, B., De Vries, H.E., Van Horssen, J., Association of Parkinson disease-related protein PINK1 with Alzheimer disease and multiple sclerosis brain lesions. Free Radic. Biol. Med. 50 (2011), 469–476.
269. Winklhofer, K.F., Haass, C., Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta 1802 (2010), 29–44.
270. Witte, M.E., Nijland, P.G., Drexhage, J.A., Gerritsen, W., Geerts, D., Van Het Hof, B., Reijerkerk, A., De Vries, H.E., Van Der Valk, P., Van Horssen, J., Reduced expression of PGC-1alpha partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol. 125 (2013), 231–243.
271. Wong-Riley, M.T., Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12 (1989), 94–101.
272. Wu, J., Huang, Z., Ren, J., Zhang, Z., He, P., Li, Y., Ma, J., Chen, W., Zhang, Y., Zhou, X., Yang, Z., Wu, S.Q., Chen, L., Han, J., Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 23 (2013), 994–1006.
273. Ye, X., Sun, X., Starovoytov, V., Cai, Q., Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains. Hum. Mol. Genet. 24 (2015), 2938–2951.
274. Yin, X.M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K.A., Korsmeyer, S.J., Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400 (1999), 886–891.
275. Zhang, D.W., Shao, J., Lin, J., Zhang, N., Lu, B.J., Lin, S.C., Dong, M.Q., Han, J., RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325 (2009), 332–336.
276. Zhang, X., Haaf, M., Todorich, B., Grosstephan, E., Schieremberg, H., Surguladze, N., Connor, J.R., Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 52 (2005), 199–208.
277. Zhang, Z., Drzewiecki, G.J., Hom, J.T., May, P.C., Hyslop, P.A., Human cortical neuronal (HCN) cell lines: a model for amyloid beta neurotoxicity. Neurosci. Lett. 177 (1994), 162–164.
278. Zhou, Z.D., Xie, S.P., Sathiyamoorthy, S., Saw, W.T., Sing, T.Y., Ng, S.H., Chua, H.P., Tang, A.M., Shaffra, F., Li, Z., Wang, H., Ho, P.G., Lai, M.K., Angeles, D.C., Lim, T.M., Tan, E.K., F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy. Hum. Mol. Genet. 24 (2015), 6314–6330.
279. Zick, M., Rabl, R., Reichert, A.S., Cristae formation-linking ultrastructure and function of mitochondria. Biochim. Biophys. Acta 1793 (2009), 5–19.
280. Zou, J., Zhou, L., Du, X.X., Ji, Y., Xu, J., Tian, J., Jiang, W., Zou, Y., Yu, S., Gan, L., Luo, M., Yang, Q., Cui, Y., Yang, W., Xia, X., Chen, M., Zhao, X., Shen, Y., Chen, P.Y., Worley, P.F., Xiao, B., Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev. Cell 20 (2011), 97–108.